Compounds > naltrexone

naltrexone and 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer

naltrexone has been researched along with 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colloc'h, N; Perrio, C; Schmitt, S1

Other Studies

1 other study(ies) available for naltrexone and 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-isomer

ArticleYear
Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.
    European journal of medicinal chemistry, 2015, Jan-27, Volume: 90

    Topics: Dose-Response Relationship, Drug; Drug Design; Humans; Hydrocarbons, Fluorinated; Models, Molecular; Molecular Structure; Receptors, Opioid, kappa; Structure-Activity Relationship; Tetrahydroisoquinolines

2015